# The efficacy and safety of the biosimilar product (Inflectra®) compared to the reference drug (Remicade®) in rescue therapy in adult patients with ulcerative colitis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-efficacy-and-safety-of-the-biosimilar-product-inflectra-compared-to-the/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Magdalena Kaniewska,Andrzej Moniuszko,Grażyna Rydzewska |
| Citations | 27 |
| DOI | 10.5114/pg.2017.70468 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.termedia.pl/Journal/-41/pdf-30724-10?filename=the efficacy.pdf |
| OpenAlex ID | https://openalex.org/W2762105939 |
| PMID | 29123576 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Magdalena Kaniewska](https://scholariq.org/researchers/magdalena-kaniewska/)

## Paper primary topic

- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

## Paper topics

- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.